Afuco™ Anti-ITGA4 ADCC Recombinant Antibody (Etrolizumab), ADCC Enhanced (CAT#: AFC-TAB-135)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to integrin alpha 4 beta 7. Etrolizumab is a humanized monoclonal antibody designed for the treatment of inflammatory bowel disease.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized (from rat)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Etrolizumab
  • Applications
  • IF, IP, Neut, FuncS, ELISA, FC
  • Conjugate
  • Unconjugated
  • Generic Name
  • Etrolizumab
  • Related Disease
  • Ulcerative colitis (UC)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Etrolizumab; 1044758-60-2; rhuMAb Beta7; Anti-beta7; PRO145223; RG7413; ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); CD49D; integrin alpha-4; CD49d; 269C wild type; integrin alpha 4; integrin alpha-IV; VLA-4 subunit alpha;

Related Resources

  • Biosimilar Overview
Please refer to Etrolizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Etrolizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Etrolizumab"

Anti-Human Integrin alpha 4 beta 7 Recombinant Antibody (Etrolizumab)
Recombinant monoclonal antibody to integrin alpha 4 beta 7. Etrolizumab is a humanized monoclonal antibody designed for the treatment of inflammatory bowel disease.

See other products for "ITGA4"

Humanized Antibody

CAT Product Name Application Type
TAB-135 Anti-Human Integrin alpha 4 beta 7 Recombinant Antibody (Etrolizumab) IF, IP, Neut, FuncS, ELISA, FC, ICC IgG1 - kappa

Immunotoxin

CAT Product Name Application Type
AGTO-L029G anti-ITGA4 immunotoxin 15A8 (IgG)-Gel Cytotoxicity assay, Functional assay

Human Antibody

Neutralizing Antibody

CAT Product Name Application Type
NEUT-1553CQ Recombinant Rat Anti-Itga4 Antibody (CBL914) FC, Neut IgG2a, κ

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-1873 Hi-Affi™ Recombinant Rabbit Anti-ITGA4 Monoclonal Antibody (DS1873AB) ICC/IF, IHC-P, IP, WB IgG

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-135. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare